Carillon Tower Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $94.8M | Buy |
1,090,391
+814,739
| +296% | +$70.8M | 0.58% | 45 |
|
|
2020
Q3 | $21M | Sell |
275,652
-374,424
| -58% | -$28.5M | 0.28% | 129 |
|
|
2020
Q2 | $80.2M | Buy |
650,076
+102,476
| +19% | +$12.6M | 0.62% | 39 |
|
|
2020
Q1 | $46M | Buy |
547,600
+271,525
| +98% | +$22.8M | 0.45% | 63 |
|
|
2019
Q4 | $23.3M | Buy |
276,075
+196,650
| +248% | +$16.6M | 0.16% | 225 |
|
|
2019
Q3 | $5.35M | Hold |
79,425
| – | – | 0.04% | 384 |
|
|
2019
Q2 | $6.8M | Sell |
79,425
-53,450
| -40% | -$4.58M | 0.05% | 368 |
|
|
2019
Q1 | $11.8M | Buy |
132,875
+2,900
| +2% | +$258K | 0.08% | 315 |
|
|
2018
Q4 | $11.1M | Buy |
129,975
+29,000
| +29% | +$2.47M | 0.09% | 291 |
|
|
2018
Q3 | $9.79M | Sell |
100,975
-36,300
| -26% | -$3.52M | 0.07% | 339 |
|
|
2018
Q2 | $12.9M | Sell |
137,275
-142,223
| -51% | -$13.4M | 0.1% | 289 |
|
|
2018
Q1 | $21.6M | Buy |
279,498
+22,779
| +9% | +$1.76M | 0.17% | 200 |
|
|
2017
Q4 | $22.9K | Buy |
+256,719
| New | +$22.9K | 0.24% | 164 |
|